About Legend Biotech
LEGEND BIOTECH CORPORATION is an SEC registrant, classified under SIC 2834 (Pharmaceutical Preparations). It files with the SEC under Central Index Key 0001801198, and its shares are listed as LEGN on Nasdaq. Its most recent filing on EDGAR is a 4, filed November 16, 2026. 197 institutional investment managers reported holding its shares on Form 13F for Q3 2026, against 220 in Q2 2026. Its officers, directors and 10% owners have filed 15 Form 4 reports since 2026. 1 investor reports a stake of 5% or more on Schedule 13D or 13G. It reported about $270,000 of federal lobbying in the four quarters through Q3 2026.
Across SEC filings
Institutional holders · 13F
Q3 2026| Largest holders | Reported value |
|---|---|
| FMR LLC | $481.3M |
| Kynam Capital Management LP | $182.1M |
| HHLR ADVISORS LTD | $166.3M |
| DEERFIELD MANAGEMENT COMPANY L P SERIES C | $161.9M |
| SUVRETTA CAPITAL MANAGEMENT LLC | $123.9M |
5%+ holders · 13D/G
1 filer| Filer | % of class | Filed |
|---|---|---|
| FMR LLC 13G | 12.4% | 2026-11-05 |
Latest Schedule 13D or 13G from each filer; stakes a filer has reported closed are left out.
Securities
| CUSIP | Security | Type |
|---|---|---|
| 52490G102 | LEGN LEGEND BIOTECH CORP-ADR | Adr |
Insider trades · Form 4
Latest filings
- Peter Salovey 2026-11-16 Buy
- (corsee) D. Sanders Corazon 2026-10-01 Sell
- Peter Salovey 2026-09-28 Award
- Tomas J. Heyman 2026-09-28 Award
- Li Mao 2026-09-28 Award